The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2016

Filed:

Aug. 29, 2013
Applicants:

Chong Kun Dang Pharmaceutical Corp., Seoul, KR;

Inje University Industry-academic Cooperation Foundation, Gimhae-si, KR;

Inventors:

HoJin Choi, Yongin-si, KR;

JaeWon Lee, Yongin-si, KR;

ChangGon Lee, Yongin-si, KR;

NiNa Ha, Yongin-si, KR;

Su Kil Seo, Busan, KR;

SunMi Lee, Busan, KR;

Song-Min Lee, Sangju-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/12 (2006.01); C07D 209/08 (2006.01); C07D 409/14 (2006.01); C07D 403/12 (2006.01); C07D 401/14 (2006.01); C07D 235/08 (2006.01); C07D 401/12 (2006.01); C07D 405/12 (2006.01); C07D 285/14 (2006.01);
U.S. Cl.
CPC ...
C07D 409/14 (2013.01); C07D 209/08 (2013.01); C07D 235/08 (2013.01); C07D 285/14 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 409/12 (2013.01);
Abstract

The present invention relates to novel N-acylhydrazone derivatives, and more particularly to novel N-acylhydrazone derivatives having selective T cell inhibitory activity and/or anti-lymphoid malignancy activity, stereoisomers thereof, pharmaceutically acceptable salts thereof, the use thereof for preparing pharmaceutical compositions, pharmaceutical compositions containing the same, treatment methods using the compositions, and methods for preparing the novel N-acylhydrazone derivatives.


Find Patent Forward Citations

Loading…